Related Experiment Video

Updated: Aug 19, 2026

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury
05:59

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Published on: August 30, 2019

Limitations of MELD in Isolated Polycystic Liver Disease: Fatal Traumatic Cyst Rupture Complicated by Abdominal

Zachary C Vinton1, Carter A Schulz1, Stephanie J Melquist2

  • 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu.

Case Reports in Hepatology
|August 18, 2026
PubMed

Insights

Polycystic liver disease (PLD) can cause severe symptoms not reflected in standard transplant scores. This case highlights the need for reassessment and the potential for rare, fatal complications in PLD patients.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Medical Genetics

Background:

  • Isolated polycystic liver disease (PLD) is a rare condition causing significant symptoms despite normal liver function.
  • The Model for End-Stage Liver Disease (MELD) score may underestimate disease severity in PLD patients due to uncaptured burdens.
  • Recent MELD exception guidelines now consider malnutrition and sarcopenia in PLD.

Purpose of the Study:

  • To describe a case of isolated PLD with progressive decline and MELD exception.
  • To emphasize the importance of longitudinal reassessment in PLD patients.
  • To highlight rare but severe complications associated with PLD.

Main Methods:

  • Case report of a patient with isolated PLD.
  • Evaluation of MELD score limitations in PLD.
  • Review of MELD exception criteria for PLD.
  • Documentation of clinical course, including complications.

Main Results:

  • The patient developed progressive weight loss, sarcopenia, and functional decline, necessitating MELD exception.
  • The patient was listed for transplant but died due to hepatic cyst rupture, hemoperitoneum, and abdominal compartment syndrome.
  • This outcome underscores the unpredictable and potentially fatal nature of PLD complications.

Conclusions:

  • Symptomatic PLD requires careful, longitudinal evaluation beyond standard scoring systems.
  • MELD exception criteria are crucial for patients with advanced PLD and associated complications.
  • Rare complications like hepatic cyst rupture can be rapidly fatal in PLD patients.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Appendicitis01:19

Appendicitis

Appendicitis is an acute inflammatory condition of the vermiform appendix, most commonly caused by obstruction of its lumen. The appendix is a narrow, blind-ended pouch that extends from the cecum, making it particularly prone to obstruction. Causes include fecaliths, lymphoid hyperplasia (often after viral infections), parasites, tumors, or foreign bodies. This obstruction initiates a cascade of pathological changes.Luminal Obstruction and Early InflammationAfter obstruction, normal mucosal...